LJI Wealth Management »

Xeris Pharmaceuticals shares owned by LJI Wealth Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by LJI Wealth Management from 13F filings

Historical chart of LJI Wealth Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by LJI Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by LJI Wealth Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $114k 61k 1.86
2023-06-30 $186k 71k 2.62
2023-03-31 $124k 76k 1.63
2022-12-31 $144k 108k 1.33

More positions owned by LJI Wealth Management

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple Put Option (AAPL)
Amplify Etf Tr High Income (YYY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus Mid Cap Etf (IWR)
Vanguard Scottsdale Fds Vng Rus2000grw (VTWG)
Vanguard Admiral Fds Midcp 400 Grth (IVOG)
Invesco Exchange Traded Fd T Dorsey Wright Mo (PDP)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
JPMorgan Chase & Co. (JPM)

View all positions for LJI Wealth Management

Top funds holding Xeris Pharmaceuticals

Vanguard Group
Rosalind Advisors
Millennium Management
D. E. Shaw & Co
Redmile Group
Citadel Advisors
Invenomic Capital Management
Tudor Investment Corporation
Lazard Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Jpmorgan Chase & Co
Rubric Capital Management
Barclays
AQR Capital Management

View all funds holding Xeris Pharmaceuticals